23andMe Gets NHGRI Grant | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genetic testing firm 23andMe said today it has received a $190,000 grant from the National Institutes of Health to validate its platform for pharmacogenomics research.

The Mountain View, Calif.-based company received the funding as part of the American Recovery and Reinvestment Act of 2009 from NIH's National Human Genome Research Institute.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The White House has created a list of cuts, including to the NIH, that could be in a budget bill for this year.

The US National Institutes of Health is to allow applicants to cite preprints just as they would any other research paper, ScienceInsider reports.

Two manuscript pages handwritten by Charles Darwin are going on the auction block, according to the Los Angeles Times.

In PNAS this week: tool to track transcriptome-wide binding, evidence of balancing selection on behavior-linked genes, and more.